Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill M Williams

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Journal of Dual Diagnosis|May 10, 2017
Building a Research Agenda for Reducing Smoking and Other Cardiovascular Risk FactorsAmanda L Baker, Jill M Williams
The American Journal of the Medical Sciences|October 15, 2003
Serious mental illness and tobacco addiction: a model program to address this common but neglected issueDouglas Ziedonis, Jill M Williams, David Smelson
Lancet (London, England)|August 18, 2016
Opioid analgesicsHenri-Jean Aubin, Jill M Williams, Amandine Luquiens
Psychiatric Services (Washington, D.C.)|September 4, 2004
A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophreniaJill M Williams, Douglas M Ziedonis, Jonathan Foulds
The New England Journal of Medicine|May 6, 2006
Racial differences in lung cancerJonathan Foulds, Jill M Williams, Kunal K Gandhi
Intellectual and Developmental Disabilities|June 4, 2009
Tobacco use among individuals with intellectual or developmental disabilities: a brief reviewMarc L Steinberg, Laura Heimlich, Jill M Williams
American Journal of Preventive Medicine|June 15, 2015
Poor Mental Health and Reduced Decline in Smoking PrevalenceMarc L Steinberg, Jill M Williams, Yunqing Li
JAMA Psychiatry|November 1, 2013
Partnership between tobacco control programs and offices of mental health needed to reduce smoking rates in the United StatesJill M Williams, Jeffrey G Willett, Gregory Miller
Applied Microbiology and Biotechnology|May 25, 2012
Whey fermentation: on-line analysis of lactose and lactic acid by FTIR spectroscopyPaul Fairbrother, William O George, Jill M Williams
Addictive Behaviors|April 1, 2018
Varenicline for smoking reduction in smokers not yet ready to quit: A double-blind, proof-of-concept randomized clinical trialMarc L Steinberg, Shou-En Lu, Jill M Williams
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Journal of Dual Diagnosis|May 10, 2017
Building a Research Agenda for Reducing Smoking and Other Cardiovascular Risk FactorsAmanda L Baker, Jill M Williams
The American Journal of the Medical Sciences|October 15, 2003
Serious mental illness and tobacco addiction: a model program to address this common but neglected issueDouglas Ziedonis, Jill M Williams, David Smelson
Lancet (London, England)|August 18, 2016
Opioid analgesicsHenri-Jean Aubin, Jill M Williams, Amandine Luquiens
Psychiatric Services (Washington, D.C.)|September 4, 2004
A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophreniaJill M Williams, Douglas M Ziedonis, Jonathan Foulds
The New England Journal of Medicine|May 6, 2006
Racial differences in lung cancerJonathan Foulds, Jill M Williams, Kunal K Gandhi
Intellectual and Developmental Disabilities|June 4, 2009
Tobacco use among individuals with intellectual or developmental disabilities: a brief reviewMarc L Steinberg, Laura Heimlich, Jill M Williams
American Journal of Preventive Medicine|June 15, 2015
Poor Mental Health and Reduced Decline in Smoking PrevalenceMarc L Steinberg, Jill M Williams, Yunqing Li
JAMA Psychiatry|November 1, 2013
Partnership between tobacco control programs and offices of mental health needed to reduce smoking rates in the United StatesJill M Williams, Jeffrey G Willett, Gregory Miller
Applied Microbiology and Biotechnology|May 25, 2012
Whey fermentation: on-line analysis of lactose and lactic acid by FTIR spectroscopyPaul Fairbrother, William O George, Jill M Williams
Addictive Behaviors|April 1, 2018
Varenicline for smoking reduction in smokers not yet ready to quit: A double-blind, proof-of-concept randomized clinical trialMarc L Steinberg, Shou-En Lu, Jill M Williams
Pageof 10